PlainLanguageRx: Improving Medication Labels to Reduce Health Disparities
NCT ID: NCT01622686
Last Updated: 2012-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
470 participants
INTERVENTIONAL
2011-11-30
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PictureRx: An Intervention to Reduce Latino Health Disparities (Supplement: Medical Icons)
NCT01618461
Enhanced Prescription Drug Label to Improve Patient Understanding and Use
NCT00973180
Improving Prescription Drug Warning Labels
NCT00846209
FDA "Breakthrough Drugs": A Trial Testing the Effect of Alternative Language on Public Perceptions
NCT02428556
Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-management
NCT02820038
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Traditional prescription drug labels
Routine drug labels provided by the participating pharmacies
No interventions assigned to this group
Reformatted medication labels
Prescription drug container labels that follow a new format and also include illustrations
PictureRx medication label
Reformatted medication labels that adhere to current best practices for label design and also include illustrations
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PictureRx medication label
Reformatted medication labels that adhere to current best practices for label design and also include illustrations
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fluency in English or Spanish
* Manage their own prescription medicines, and
* Have recently filled at least 1 new prescription medication (e.g, a medicine or medication dose that they have not taken before) and have their new prescription bottle information with them.
Exclusion Criteria
* Too ill to participate in an interview
* Do not have a telephone
* Having visual acuity worse than 20/50 via Rosenbaum Visual Acuity exam (eyechart)
* Persons picking up new medicines for others
* Inability to communicate in either Spanish or English
* Overt psychiatric illnesses, overt delirium or dementia
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
PictureRx, LLC
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
M Brian Riley
Director of Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
M Brian Riley, MA
Role: PRINCIPAL_INVESTIGATOR
PictureRx, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PictureRx, LLC (SAI Interactive)
Chattanooga, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.